A hydrogel-based implantable multidrug antitubercular formulation outperforms oral delivery. Issue 31 (30th July 2021)

• Record Type: Journal Article
• Authors: Pal, Sanjay; Soni, Vijay; Kumar, Sandeep; Jha, Somesh Kumar; Medatwal, Nihal; Rana, Kajal; Yadav, Poonam; Mehta, Devashish; Jain, Dolly; Sharma, Pankaj; Kar, Raunak; Srivastava, Aasheesh; Patil, Veena S.; Dasgupta, Ujjaini; Nandicoori, Vinay Kumar; Bajaj, Avinash
• Is Part Of: Nanoscale. Volume 13:Issue 31(2021)
• Page Start: 13225
• Page End: 13230
• Publication Date: 2021-07-30
• Subjects: Nanoscience -- Periodicals; Nanotechnology -- Periodicals; 620.505
• DOI: 10.1039/d0nr08806d
• Languages: English
• ISSNs: 2040-3364

Abstract

Abstract : We showed that hydrogel-mediated delivery of a combination of anti-tuberculosis drugs is more effective than oral delivery against tuberculosis. Abstract : We present a non-immunogenic, injectable, low molecular weight, amphiphilic hydrogel-based drug delivery system (TB-Gel) that can entrap a cocktail of four front-line antitubercular drugs, isoniazid, rifampicin, pyrazinamide, and ethambutol. We showed that TB-Gel is more effective than oral delivery of the combination of four drugs in reducing the mycobacterial infection in mice. Results show that half the dose of chemotherapeutic drugs is sufficient to achieve a comparable therapeutic effect to that of oral delivery.